COMPOSITION FOR TREATMENT OF PATIENTS WITH SQUAMOUS-HYPER- -KERATOTIC RUBROMYCOSIS FORM OF FOOT AND WRIST

medicine, pharmacy. SUBSTANCE: composition has the following components, wt. -%: mixture of 4-nitro- and 6-nitro-5,7-dichlorobenzenefuroxanes in the ratio of indicated components 30:70, 0.30-0.60; polyethylene glycol-400, 79.65-79.80; polyethylene glycol-1500, 16.95-17.10; dmethylsulfoxide, 2.80. In...

Full description

Saved in:
Bibliographic Details
Main Authors TORBINA O.V, FRIZIN V.V, BUZYKIN B.I, MOLODYKH ZH.V, GARIPOV T.V, FALJAKHOV I.F, KUKLIN V.T, JUSUPOVA L.M, VOLOSHINA A.D
Format Patent
LanguageEnglish
Published 27.06.2001
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:medicine, pharmacy. SUBSTANCE: composition has the following components, wt. -%: mixture of 4-nitro- and 6-nitro-5,7-dichlorobenzenefuroxanes in the ratio of indicated components 30:70, 0.30-0.60; polyethylene glycol-400, 79.65-79.80; polyethylene glycol-1500, 16.95-17.10; dmethylsulfoxide, 2.80. In topical treatment of squamous-hyperkeratotic form of rubromycosis of foots and wrists caused by fungus Trichophyton rubrum the composition exhibits simultaneous fungicide effect and effect normalizing the keratinization process. EFFECT: enhanced effectiveness of treatment. 9 tbl, 2 dwg, 6 ex
Bibliography:Application Number: RU19980112830